Daily non-political popular news in brief.
Clinical trial evaluating brain cancer vaccine is underway at NYU
10-18-2007 · EurekAlert!A clinical trial evaluating a brain cancer vaccine in patients with newly diagnosed brain cancer has begun at NYU Medical Center. The study will evaluate the addition of the vaccine following standard therapy with surgery and chemotherapy in patients with glioblastoma multiforme, a deadly form of brain cancer.
Read more »
Keywords: clinical, trial, evaluating, brain, cancer, vaccine, underway, nyu
« Previous | Next »
Similar news on "Clinical trial evaluating brain cancer vaccine is underway at NYU":
- Vaccine for brain tumors shows promising results
11-16-2006 · EurekAlert!
A vaccine for treating a recurrent cancer of the central nervous system that occurs primarily in the brain, known as glioma, has shown promising results in preliminary data from a clinical trial at UCSF Medical Center.
Similar news · Read more »
- Mayo Clinic tests novel vaccine for aggressive brain tumors
10-22-2007 · EurekAlert!
A vaccine that has significantly increased life expectancy in early tests of patients with glioblastoma multiforme -- the most common, most aggressive form of brain cancer in adults -- is now being offered through a clinical trial at Mayo Clinic in Jacksonville.
Similar news · Read more »
- UCSF brain tumor vaccine trial shows promising results
04-16-2007 · EurekAlert!
A vaccine for treating a recurrent cancer of the central nervous system that occurs primarily in the brain has shown promise in preliminary data from a clinical trial at the University of California, San Francisco.
Similar news · Read more »
- New mammography technology improves cancer detection
11-28-2007 · EurekAlert!
A new radiological diagnostic tool called stereo mammography allows clinicians to detect more lesions and could significantly reduce the number of women who are recalled for additional tests following routine screening mammography. The findings from a clinical trial underway at Emory University were presented today at the annual meeting of the Radiological Society of North America held in Chicago.
Similar news · Read more »
- Other highlights in the November 1 JNCI
10-31-2006 · EurekAlert!
Other highlights in the November 1 issue of JNCI include a review of statins and fibrates for action against melanoma, a study of a virus that kills brain tumors in mice, an antibody that decreases ovarian cancer growth in mice and a study that describes the use of the immunohistochemical assay in predicting clinical trial results for breast cancer patients.
Similar news · Read more »
- New angiogenesis inhibitor has promise for treating deadly brain tumor
01-16-2007 · EurekAlert!
Researchers from the Massachusetts General Hospital Cancer Center have found that AZD2171, a new angiogenesis inhibitor, can significantly reduce the size of the deadly brain tumors called glioblastomas and has the potential of improving the effectiveness of other therapeutic techniques. The Phase 2 clinical trial also finds that the new drug can alleviate brain swelling (edema), a debilitating symptom in many brain cancer patients that currently can be treated only with steroid drugs.
Similar news · Read more »
- Drug shows activity against brain metastases
06-03-2007 · EurekAlert!
The drug lapatinib shrank tumors and slowed progression of brain metastases in some patients with advanced breast cancer, according to results of a clinical trial being presented by Dana-Farber Cancer Institute scientists at the annual meeting of the American Society of Clinical Oncology.
Similar news · Read more »
- Phase II study of therapeutic vaccine shows efficacy in patients with metastatic colorectal cancer
08-01-2007 · EurekAlert!
A therapeutic cancer vaccine has shown effectiveness when given alongside chemotherapy to patients with metastatic colorectal cancer in a phase II trial, according to research published in the Aug. 1 issue of the journal Clinical Cancer Research.
Similar news · Read more »
- New chemotherapy regimen prolongs survival in difficult-to-treat childhood brainstem gliomas
09-25-2007 · EurekAlert!
Spanish researchers told the European Cancer Conference in Barcelona that they have found that a chemotherapy regimen of irinotecan and cisplatin produced rapid clinical responses in childhood brain stem glioma, and shrank the tumors by more than 20 percent in all six children enrolled in a clinical trial.
Similar news · Read more »
- Mayo Clinic Cancer Center: Harnessing the measles virus to attack cancer
10-30-2006 · EurekAlert!
Mayo Clinic Cancer Center has opened a new clinical study using a vaccine strain of the measles virus to attack recurrent glioblastoma multiforme, a largely untreatable brain tumor.
Similar news · Read more »
